Annual Meeting

Keep your friends close and your RNAs closer

A Discover BMB symposium: Regulation of RNA
Stacy Horner Daniel Dominguez
By Stacy Horner and Daniel Dominguez
Sept. 29, 2022

The importance of understanding RNA biology never has been more apparent. Not only did an RNA virus cause a global pandemic, COVID-19, but an RNA-based vaccine has the power to end it. RNA biology is complex and fascinating, and alterations to its function often lead to disease.

How much do you really know about RNA? How is RNA regulated? What does RNA do in the cell? What happens when RNA regulation goes wrong? What are the latest approaches to studying RNA function?

Our symposia at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, in Seattle in March is organized around these important questions and will feature a diverse set of experts on these topics.

Keywords: RNA modifications, epitranscriptome, RNA localization, splicing, viral RNA, RNA binding proteins, RNA structure.

Who should attend: Everyone who is curious about the diverse biology regulated by RNA, how RNA works and the latest methods to study its function.

Theme song: “Message in a Bottle” by The Police.

This session is powered by ribonucleic acid, its modifications and the interacting proteins.

Speakers

RNA binding proteins and disease
Daniel Dominguez (chair), University of North Carolina at Chapel Hill
Brenda L. BassUniversity of Utah
Alfredo CastelloMedical Research Council–University of Glasgow Centre for Virus Research
Kristen LynchUniversity of Pennsylvania School of Medicine

RNA modifications: discovery and function
Stacy Horner (chair), Duke University School of Medicine
Lydia M. ContrerasUniversity of Texas at Austin
Kate MeyerDuke University School of Medicine
Jordan MeierNational Cancer Institute

Novel RNAs: localization, form, function
Silvi RouskinHarvard Medical School
Eliezer CaloMassachusetts Institute of Technology
Grace ChenYale University
Matthew Taliaferro (chair), University of Colorado Anschutz Medical Campus

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Stacy Horner
Stacy Horner

Stacy Horner is an associate professor at Duke University.

Daniel Dominguez
Daniel Dominguez

Daniel Dominguez is an assistant professor at the University of North Carolina School of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.